NI
AMAG

Numeric Investors’s AMAG Pharmaceuticals AMAG Stock Holding History

Numeric Investors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$3.58M Sell
269,983
-80,861
-23% -$1.22M 0.03% 488
2017
Q3 		$6.47M Sell
350,844
-259,100
-42% -$4.83M 0.05% 353
2017
Q2 		$11.2M Sell
609,944
-408,300
-40% -$8.09M 0.1% 204
2017
Q1 		$23M Buy
1,018,244
+80,112
+9% +$1.92M 0.21% 123
2016
Q4 		$32.6M Buy
938,132
+499,834
+114% +$14.9M 0.3% 77
2016
Q3 		$10.7M Buy
+438,298
New +$11M 0.1% 213
2016
Q2 		– Sell
-255,500
Closed -$5.98M – 1229
2016
Q1 		$5.98M Buy
255,500
+241,700
+1,751% +$5.74M 0.06% 267
2015
Q4 		$417K Sell
13,800
-71,900
-84% -$2.32M ﹤0.01% 772
2015
Q3 		$3.4M Buy
85,700
+39,100
+84% +$2.43M 0.04% 303
2015
Q2 		$3.22M Buy
46,600
+23,600
+103% +$1.48M 0.04% 321
2015
Q1 		$1.26M Buy
+23,000
New +$1.1M 0.02% 428
2014
Q1 		– Sell
-121,351
Closed -$2.95M – 939
2013
Q4 		$2.95M Sell
121,351
-40,815
-25% -$960K 0.05% 299
2013
Q3 		$3.48M Buy
162,166
+133,297
+462% +$3.15M 0.06% 267
2013
Q2 		$642K Buy
+28,869
New +$636K 0.01% 472

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Numeric Investors's AMAG Position: Q4 2017 in Review

Numeric Investors reduced its AMAG Pharmaceuticals (AMAG) stake by 23% in Q4 2017, selling an estimated $1.22M and leaving 269,983 shares worth $3.58M. The position accounts for 0.03% of the portfolio, ranked #488.

Numeric Investors first reported a position in AMAG in Q2 2013 and has held it in 14 quarters since. The position peaked at $32.6M in Q4 2016. 170 funds tracked by Wall St. Rank hold AMAG as of Q4 2017.

  • Numeric Investors held 269,983 shares of AMAG Pharmaceuticals worth $3.58M as of Q4 2017.
  • Numeric Investors sold 80,861 AMAG Pharmaceuticals shares in Q4 2017, an estimated $1.22M.
  • AMAG Pharmaceuticals made up 0.03% of Numeric Investors's portfolio in Q4 2017, its #488 holding.
  • Numeric Investors first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 14 quarters since.
  • Numeric Investors's AMAG Pharmaceuticals position peaked at $32.6M in Q4 2016.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.